Value assessment frameworks
Some frameworks may undermine personalized medicine
A new study authored by Xcenda finds that many value assessment frameworks still make sweeping conclusions about the economic worth of a treatment based almost exclusively on population averages. As a result, frameworks could unintentionally discourage payers and providers from considering important information about a patient’s biology and preferences that can improve health outcomes.
Read the white paper